HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 13 July 2015

Recently published CEAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. From the ones listed this time, here's a few in our areas of research interest:

Karnon J, Partington A. Cost-Value Analysis and the SAVE: A Work in Progress, But an Option for Localised Decision Making? Pharmacoeconomics. 2015 Jun 23. [Epub ahead of print] PubMed PMID: 26100285.

Svensson M, Nilsson FO, Arnberg K. Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. Pharmacoeconomics. 2015 Jun 21. [Epub ahead of print] PubMed PMID: 26093889.

Katz G, Romano O, Foa C, et. al. Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France. PLoS One. 2015 Jun 18;10(6):e0128880. eCollection 2015. PubMed PMID: 26086912.

Losina E, Dervan EE, Paltiel AD, et. al. Defining the Value of Future Research to Identify the Preferred Treatment of Meniscal Tear in the Presence of Knee Osteoarthritis. PLoS One. 2015 Jun 18;10(6):e0130256. eCollection 2015. PubMed PMID: 26086246.